Chargement en cours...
SHP2 phosphatase as a novel therapeutic target for melanoma treatment
Melanoma ranks among the most aggressive and deadly human cancers. Although a number of targeted therapies are available, they are effective only in a subset of patients and the emergence of drug resistance often reduces durable responses. Thus there is an urgent need to identify new therapeutic tar...
Enregistré dans:
| Publié dans: | Oncotarget |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Impact Journals LLC
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342016/ https://ncbi.nlm.nih.gov/pubmed/27650545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12074 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|